Clinical Trial: PRidopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington's Disease

U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609108) titled 'PRidopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington's Disease' on May 20.

Brief Summary: The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine.

The main questions the study aims to answer are:

Does pridopidine slow the overall worsening of HD over 1 year? Does pridopidine slow the worsening of specific aspects of HD over 1 year, namely the clinical progression, the ability to perform daily life activities (functional capacity), the mind's ability to process informatio...